-
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
NCT06283966 ·
Phase: Phase 3 ·
Ages: 40 Years to 80 Years ·
Sex: All (male and female)
· Florida: Boynton Beach, Bradenton, Cape Coral, Clearwater
-
A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
NCT07646587 ·
Phase: Phase 2 ·
Ages: 40 Years to 80 Years ·
Sex: All (male and female)
· Florida: Miami Lakes
-
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
NCT07053423 ·
Phase: Phase 4 ·
Ages: 40 Years to 85 Years ·
Sex: All (male and female)
· Florida: Miami
-
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
NCT07082738 ·
Phase: Phase 2 ·
Ages: 40 Years and older ·
Sex: All (male and female)
· Florida: Brandon, Cape Coral, Clearwater, Jacksonville
-
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
NCT07780669 ·
Phase: Phase 3 ·
Ages: 40 Years to 80 Years ·
Sex: All (male and female)
· Florida: Doral
-
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
NCT06883305 ·
Phase: Phase 3 ·
Ages: 40 Years to 80 Years ·
Sex: All (male and female)
· Florida: Clearwater, Cutler Bay, DeBary, Gainesville
-
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
NCT06878261 ·
Phase: Phase 3 ·
Ages: 40 Years to 80 Years ·
Sex: All (male and female)
· Florida: Bay Pines, Boynton Beach, Clearwater, Fleming Island
-
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
NCT07363694 ·
Phase: Phase 2, Phase 3 ·
Ages: 35 Years to 80 Years ·
Sex: All (male and female)
· Florida: Greenacres City, Kissimmee, Loxahatchee Groves, Miami
-
Alpha-1 Research Registry
NCT04157049 ·
Phase: Not specified ·
Ages: No age limits stated ·
Sex: All (male and female)
· Florida: Coral Gables
-
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
NCT06035120 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 40 Years to 80 Years ·
Sex: All (male and female)
· Florida: Orlando
-
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
NCT06891755 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 40 Years to 84 Years ·
Sex: All (male and female)
· Florida: Jacksonville, Orlando
-
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
NCT07059091 ·
Phase: Phase 2 ·
Ages: 40 Years and older ·
Sex: All (male and female)
· Florida: Jacksonville
-
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
NCT06122077 ·
Phase: Not specified ·
Ages: 50 Years and older ·
Sex: All (male and female)
· Florida: DeLand, Doral, Kissimmee, Port Orange
-
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
NCT06959095 ·
Phase: Phase 3 ·
Ages: 40 Years to 80 Years ·
Sex: All (male and female)
· Florida: Loxahatchee Groves, Miami
-
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
NCT06961214 ·
Phase: Phase 3 ·
Ages: 40 Years to 80 Years ·
Sex: All (male and female)
· Florida: Brooksville, Doral, Fort Lauderdale, Miami
-
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
NCT07190209 ·
Phase: Phase 3 ·
Ages: 40 Years to 80 Years ·
Sex: All (male and female)
· Florida: Boynton Beach, Cutler Bay, Fort Myers, Lady Lake
-
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
NCT07190222 ·
Phase: Phase 3 ·
Ages: 40 Years to 80 Years ·
Sex: All (male and female)
· Florida: Greenacres City, Hialeah, Loxahatchee Groves, Miami
-
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
NCT07051707 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 40 Years to 80 Years ·
Sex: All (male and female)
· Florida: Jacksonville
-
Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD
NCT06578156 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 100 Years ·
Sex: All (male and female)
· Florida: Miami
-
Rademikibart IV for Acute Asthma and COPD Exacerbation
NCT07705737 ·
Phase: Phase 2 ·
Ages: 18 Years to 85 Years ·
Sex: All (male and female)
· Florida: Miami
-
STRIVE Post-Market Registry Study
NCT04302272 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Florida: Coral Gables
-
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
NCT07108166 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 40 Years and older ·
Sex: All (male and female)
· Florida: Clearwater, Coral Gables, Davie, DeBary
-
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
NCT07684820 ·
Phase: Phase 2 ·
Ages: 40 Years to 85 Years ·
Sex: All (male and female)
· Florida: Altamonte Springs, Crystal River, Leesburg, Miami
-
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
NCT07610395 ·
Phase: Phase 2 ·
Ages: 40 Years to 85 Years ·
Sex: All (male and female)
· Florida: Bradenton, Miami Lakes, Tamarac
-
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
NCT07177339 ·
Phase: Phase 3 ·
Ages: 40 Years to 75 Years ·
Sex: All (male and female)
· Florida: Brandon, Crystal River, Doral, Greenacres City
-
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
NCT05204888 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 30 Years and older ·
Sex: All (male and female)
· Florida: Jacksonville, Kissimmee, Miami, Palmetto Bay